Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
125.00    0.00 (0.00%)
Bid:
119.00
Ask:
124.50
Spread: 5.50 (4.622%)
Market Cap: £98.09m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Scheduled Trading Statement

8 Jul 2019 07:00

RNS Number : 7147E
Xaar PLC
08 July 2019
 

Xaar plc

 

Scheduled Trading Statement

 

Xaar plc ("Xaar" or the "Group"), a world leader in industrial inkjet technology, provides its scheduled trading update for the six months ended 30 June 2019.

Trading is in line with the Board's expectations and Xaar expects to report revenue of approximately £23 million for the six months ended 30 June 2019. Overall revenue for the first half was £27 million however this was impacted by approximately £4 million of revenue reversal regarding Xaar 1201 inventory being returned to the business. We anticipate selling this inventory in the second half of the year. Cash at 30 June 2019 was £21.6 million.

Excluding one-time Royalties of approximately £10 million in H1 2018 and the prior years' revenue reversal of approximately £4 million in H1 2019, revenue grew by 8%.

Underlying trading in the Printhead business has stabilised after the declines of 2018 with growth in the Industrial and Packaging segments. Growth in Industrials came from Ceramics, Décor and Advanced Manufacturing, while in Packaging growth came from Coding and Marking. As referenced above, approximately £4 million revenue in the Graphics segment has been reversed due to Xaar 1201 inventory being returned for rework due to age. We have subsequently regained control of this inventory in order to drive payment recovery and explore broader channel options. Key new printhead products have shown good growth in the first half; Xaar 2001 (43%), Xaar 501 (88%) and in particular Xaar 5601 (490%) which continues to be very positively received by customers as recently witnessed at the ITMA textile printing show in Barcelona.

Our Product Print Systems business grew by 41% driven by growth in inkjet and pad printing equipment as well as consumables.

Xaar 3D Printing is on plan with strong positive customer feedback for our new printer and we continue to work closely with Stratasys on the next phase of our partnership.

Cash balances of £21.6 million at 30 June 2019 are in line with expectations, reflecting the improved working capital profile of the business. We continue to work diligently at improving our working capital and anticipate further progress through the second half of the year.

 

We have advanced on our strategic review of the Thin Film business and will provide an update on progress at the half year results due to be announced on 10 September 2019.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

Doug Edwards, Chief Executive Officer

Shomit Kenkare, Chief Financial Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

David Ison

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development, and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKDLFBKDFLBBB
Date   Source Headline
23rd Dec 20117:02 amRNSTotal Voting Rights
23rd Dec 20117:01 amRNSBlocklisting Interim Review
23rd Dec 20117:00 amRNSIssue of Options
24th Nov 20119:58 amRNSHolding(s) in Company
18th Nov 20113:23 pmRNSBlocklisting Interim Review
17th Nov 20115:31 pmRNSHolding(s) in Company
21st Oct 201112:06 pmRNSHolding(s) in Company
20th Oct 20117:00 amRNSInterim Management Statement
11th Oct 201112:24 pmRNSHolding(s) in Company
4th Oct 201112:59 pmRNSTotal Voting Rights
30th Sep 20119:04 amRNSDirector/PDMR Shareholding
26th Sep 20115:50 pmRNSHolding(s) in Company
26th Aug 20115:21 pmRNSHolding(s) in Company
23rd Aug 20114:14 pmRNSDirector/PDMR Shareholding
18th Aug 20111:55 pmRNSHalf Yearly Report - Replacement
18th Aug 20117:00 amRNSInterim Management Statement
5th Aug 20112:59 pmRNSAdditional Listing
7th Jul 20117:00 amRNSInterim Trading Update
21st Jun 20114:34 pmRNSHolding(s) in Company
15th Jun 20117:00 amRNSHolding(s) in Company
9th Jun 20112:48 pmRNSDirector/PDMR Shareholding
8th Jun 20117:00 amRNSBoard Changes
17th May 20114:46 pmRNSResult of AGM
5th May 20117:00 amRNSNotice of 2011 AGM and AFR 2010
27th Apr 201111:54 amRNSGrant of Options
21st Apr 20117:00 amRNSInterim Management Statement
7th Apr 20118:00 amRNSDirector/PDMR Shareholding
31st Mar 201110:20 amRNSDirector/PDMR Shareholding
22nd Mar 20117:00 amRNSFinal Results
9th Mar 20114:14 pmRNSHolding(s) in Company
3rd Mar 20118:58 amRNSHolding(s) in Company
20th Jan 20117:00 amRNSYear End Trading Update
21st Dec 201011:12 amRNSGrant of Options
14th Dec 20107:00 amRNSDirectorate Change
18th Nov 20101:58 pmRNSDirector/PDMR Shareholding
15th Nov 201010:51 amRNSHolding(s) in Company
8th Nov 20102:51 pmRNSHolding(s) in Company
8th Nov 20101:48 pmRNSResult of General Meeting
8th Nov 20107:00 amRNSResults of the Placing and Open Offer
21st Oct 20104:33 pmRNSPublication of Prospectus
21st Oct 20104:33 pmRNSPublication of Prospectus
21st Oct 20107:00 amRNSIMS and fundraising
21st Oct 20107:00 amRNSIMS and fundraising
20th Sep 201011:57 amRNSHoldings in Company: Released in Error
20th Sep 201011:26 amRNSHolding(s) in Company
6th Sep 201010:03 amRNSHolding(s) in Company
6th Sep 201010:00 amRNSHolding(s) in Company
2nd Sep 20104:04 pmRNSHolding(s) in Company
24th Aug 201012:44 pmRNSHolding(s) in Company
18th Aug 20107:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.